基于低剂量CT影像组学特征预测肺癌筛查中表现为纯磨玻璃结节的浸润性腺癌
本研究基于低剂量CT构建影像组学模型,用于区分表现为纯磨玻璃结节的浸润性腺癌与原位腺癌/微浸润性腺癌,并与常规定量及语义特征、标准剂量CT影像组学模型和术中冰冻切片比较。结果显示各模型AUC在primary队列和validation队列均无显著差异(均p>0.05),低剂量CT定量-语义评分和影像组学特征具备良好预测性能,可作为术前无创生物标志物评估浸润风险。
要点
- 低剂量CT影像组学模型在primary队列区分浸润性腺癌与原位/微浸润性腺癌的AUC为0.929(95%CI 0.862-0.971)。
- 低剂量CT定量-语义模型在primary队列AUC为0.879(95%CI 0.801-0.935),validation队列为0.897(95%CI 0.768-0.968)。
- 各模型AUC在primary和validation队列均无显著差异(均p>0.05)。
核心结论
- 基于低剂量CT的定量-语义评分和影像组学特征具有良好的预测性能,可作为术前无创生物标志物评估肺癌筛查中纯磨玻璃结节的浸润风险,其性能与标准剂量CT影像组学模型相当。
研究设计与样本
- 研究纳入147例经病理证实的纯磨玻璃结节,分为primary队列(43例浸润性腺癌和60例原位/微浸润性腺癌)和validation队列(19例浸润性腺癌和25例原位/微浸润性腺癌),分别构建基于常规定量及语义特征、低剂量CT影像组学特征、标准剂量CT影像组学特征和术中冰冻切片诊断的逻辑回归模型,以AUC、敏感度和特异度评估诊断性能。
诊断标准与关键数值
- 定量-语义模型AUC在primary队列为0.879(95%CI 0.801-0.935),在validation队列为0.897(95%CI 0.768-0.968)。
- 低剂量CT影像组学模型AUC在primary队列为0.929(95%CI 0.862-0.971),在validation队列为0.933(95%CI 0.815-0.986)。
- 标准剂量CT影像组学模型AUC在primary队列为0.941(95%CI 0.876-0.978),在validation队列为0.901(95%CI 0.773-0.970)。
- 术中冰冻切片模型AUC在primary队列为0.884(95%CI 0.805-0.938),在validation队列为0.828(95%CI 0.685-0.925)。
- 各模型AUC在primary和validation队列均无显著差异(均p>0.05)。
临床应用与阅片要点
- 基于低剂量CT的定量-语义评分和影像组学特征可用于肺癌筛查中纯磨玻璃结节的术前无创浸润风险评估。
- 低剂量CT影像组学模型与标准剂量CT影像组学模型性能相当,有助于减少不必要的检查和治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop a radiomic model based on low-dose CT (LDCT) to distinguish invasive adenocarcinomas (IAs) from adenocarcinoma in situ/minimally invasive adenocarcinomas (AIS/MIAs) manifesting as pure ground-glass nodules (pGGNs) and compare its performance with conventional quantitative and semantic features of LDCT, radiomic model of standard-dose CT, and intraoperative frozen section (FS).
METHODS: A total of 147 consecutive pathologically confirmed pGGNs were divided into primary cohort (43 IAs and 60 AIS/MIAs) and validation cohort (19 IAs and 25 AIS/MIAs). Logistic regression models were built using conventional quantitative and semantic features, selected radiomic features of LDCT and standard-dose CT, and intraoperative FS diagnosis, respectively. The diagnostic performance was assessed by area under curve (AUC) of receiver operating characteristic curve, sensitivity, and specificity.
RESULTS: The AUCs of quantitative-semantic model, radiomic model of LDCT, radiomic model of standard-dose CT, and FS model were 0.879 (95% CI, 0.801-0.935), 0.929 (95% CI, 0.862-0.971), 0.941 (95% CI, 0.876-0.978), and 0.884 (95% CI, 0.805-0.938) in the primary cohort and 0.897 (95% CI, 0.768-0.968), 0.933 (95% CI, 0.815-0.986), 0.901 (95% CI, 0.773-0.970), and 0.828 (95% CI, 0.685-0.925) in the validation cohort. No significant difference of the AUCs was found among these models in both the primary and validation cohorts (all p > 0.05).
CONCLUSION: The LDCT-based quantitative-semantic score and radiomic signature, with good predictive performance, can be pre-operative and non-invasive biomarkers for assessing the invasive risk of pGGNs in lung cancer screening.
ADVANCES IN KNOWLEDGE: The LDCT-based quantitative-semantic score and radiomic signature, with the equivalent performance to the radiomic model of standard-dose CT, can be pre-operative predictors for assessing the invasiveness of pGGNs in lung cancer screening and reducing excess examination and treatment.
引用
- Li, Liu, Yang, et al. Prediction of invasive adenocarcinomas manifesting as pure ground-glass nodules based on radiomic signature of low-dose CT in lung cancer screening. Br J Radiol. 2022. PMID: 34995082. doi:10.1259/bjr.20211048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。